These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2707124)

  • 21. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Campylobacter pylori in the stomach, duodenum and colon of gastroenterological patients. An epidemiologic study of 120 subjects].
    Menge H; Warrelmann M; Loy V; Schmidt H; Gregor M; Skubis R; Hahn H; Riecken EO
    Dtsch Med Wochenschr; 1987 Sep; 112(37):1403-7. PubMed ID: 3622286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.
    Marshall BJ; Warren JR; Francis GJ; Langton SR; Goodwin CS; Blincow ED
    Am J Gastroenterol; 1987 Mar; 82(3):200-10. PubMed ID: 3548326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
    Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ofloxacin in the therapy of Campylobacter pylori-positive duodenal ulcer. A prospective controlled randomized study].
    Bayerdörffer E; Kasper G; Pirlet T; Sommer A; Ottenjann R
    Dtsch Med Wochenschr; 1987 Sep; 112(37):1407-11. PubMed ID: 3304929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
    Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
    J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with Campylobacter pylori in western Kentucky.
    Kraus JW; Morello PJ
    J Ky Med Assoc; 1989 Sep; 87(9):448-50. PubMed ID: 2794757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Campylobacter pylori, gastritis and peptic ulcer].
    Hirschl AM; Stanek G; Rotter M; Pötzi R; Gangl A; Hentschel E; Schütze K; Holzner HJ; Nemec H
    Wien Klin Wochenschr; 1987 Jul; 99(14):493-7. PubMed ID: 3630180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
    Gisbert JP; Boixeda D; Alvarez Baleriola I; Redondo C; De Rafael L; Martín de Argila C; Hernández Ranz F
    Rev Esp Enferm Dig; 1995 Apr; 87(4):281-7. PubMed ID: 7794634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
    J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Campylobacter pylori: associations with antral and fundic mucosal histology and diagnosis by serology in patients with upper gastrointestinal symptoms.
    Cohen H; Gramisu M; Fitzgibbons P; Appleman M; Skoglund M; Valenzuela JE
    Am J Gastroenterol; 1989 Apr; 84(4):367-71. PubMed ID: 2648815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Campylobacter pylori. Diagnosis and treatment.
    Tytgat GN; Rauws EA; de Koster EH
    J Clin Gastroenterol; 1989; 11 Suppl 1():S49-53. PubMed ID: 2681390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s).
    Elta GH; Murphy R; Behler EM; Barnett JL; Nostrant TT; Kern S; Appelman H
    Am J Gastroenterol; 1989 Jun; 84(6):643-6. PubMed ID: 2729235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.
    Wagner S; Gebel M; Haruma K; Bär W; Lange P; Freise J; Gladziwa U; Schmidt FW
    Gut; 1992 Feb; 33(2):179-83. PubMed ID: 1347278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer.
    Eberhardt R; Kasper G
    Rev Infect Dis; 1990; 12 Suppl 1():S115-9. PubMed ID: 2406852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.
    Rauws EA; Langenberg W; Houthoff HJ; Zanen HC; Tytgat GN
    Gastroenterology; 1988 Jan; 94(1):33-40. PubMed ID: 3335295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.